Derma Sciences, Inc. DSCI
7.00 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
6.96 Day range 7.05
2.92 52-week range 7.05
- EPS (ttm)
- -347.22
- P/E ratio
- -0.02
- Volume
- 57.50K
- Avg volume
- 149.72K
- Open
- 7.00
- Previous close
- 7.00
- Day's range
- 6.96 – 7.05
- 52-week range
- 2.92 – 7.05
- Earnings date
- Mar 15, 2017
No chart data for this range yet.
Next earnings
Mar 15, 2017
Expected Mar 15, 2017. Consensus EPS estimate -0.04.
Financials — quick view
DSCI Revenue — quarterly 21.81M
DSCI Net income — quarterly -1.39M
DSCI EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 15, 2017 | Dec 1, 2016 | -0.04 | — | — | — |
| Nov 10, 2016 | Sep 1, 2016 | -0.04 | — | — | — |
| Aug 9, 2016 | Jun 1, 2016 | -0.08 | — | — | — |
| May 11, 2016 | Mar 1, 2016 | -0.13 | — | — | — |
| Mar 16, 2016 | Dec 1, 2015 | -0.39 | — | — | — |
| Nov 9, 2015 | Sep 1, 2015 | -0.43 | — | — | — |
News
Derma Sciences Reports 2016 Third Quarter Financial Results 
Derma Sciences Reports 2016 Second Quarter Financial Results 
Derma Sciences to Acquire BioD, Solidify Its Leadership Position in
Advanced Wound Care and Regenerative Products 
Derma Sciences Reports 2016 First Quarter Financial Results 
Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial
Results 
Derma Sciences to Hold Conference Call on November 12 to Discuss Data
Monitoring Committee Pre-Specified Interim Analysis of the Aclerastide
Phase 3 Trials 
Derma Sciences Reports Third Quarter 2015 Financial Results 
CORRECTING and REPLACING Derma Sciences Reports Second Quarter
Financial Results 
Derma Sciences Reports First Quarter 2015 Financial Results 
Derma Sciences Reports Fourth Quarter and Year Ended Financial Results
Your note
Sign in to keep a note on DSCI — it syncs with the Stock Master app.